Elevance Health, Inc. ( (ELV) ) has released its Q1 earnings. Here is a breakdown of the information Elevance Health, Inc. presented to its investors.
Elevance Health, Inc. is a healthcare company that operates in the health insurance and services sector, providing a wide range of medical, pharmacy, behavioral, clinical, home health, and complex care solutions to over 110 million consumers.
In the first quarter of 2025, Elevance Health reported a significant increase in operating revenue, reaching $48.8 billion, a 15.4% rise from the previous year. The company also achieved an adjusted operating gain of $3.3 billion, marking a 4.1% increase, and an adjusted diluted EPS of $11.97.
Key financial highlights include a robust performance in the Carelon segment, with a 38% increase in operating revenue driven by acquisitions and product growth. The Health Benefits segment also saw an 11% revenue increase, although it faced challenges with higher medical costs in Medicaid. Despite a slight decline in operating margins, the company returned $1.3 billion to shareholders through share repurchases and dividends.
Looking ahead, Elevance Health reaffirms its full-year 2025 adjusted diluted EPS guidance, indicating a stable outlook. The company remains focused on enhancing healthcare experiences through personalized support and digital solutions, aiming to be a trusted health partner for life.